You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Antibodies (MET)
On www.antibodies-online.com are 0 Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) Antibodies from different suppliers available. Additionally we are shipping MET Kits (1) and many more products for this protein. A total of 1 MET products are currently listed.
Synonyms:
AUTS9, c-met, HGF, HGFR, MET, RCCP2
list all antibodies Gene Name GeneID UniProt
Anti-Rat MET MET 24553 P97523
Anti-Human MET MET 4233 P08581

Show all synonyms

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. PIK3CA (show PIK3CA Antibodies) and MET may play an important role in oncogenesis of certain specific subtypes of head and neck cancer

  2. The expression of c-Met and ERbeta were significantly related to the basal-like phenotype in triple-negative breast cancer, however, high c-Met expression and basal-like phenotypes did not show a direct correlation with poor prognosis

  3. HGF (show HGF Antibodies)-induced FRA1 (show FOSL1 Antibodies) activation is associated with the fibrosis-dependent development of Hepatocellular Carcinoma.

  4. NEAT1 functions a molecular sponge for miR-449b-5p and leads to the upregulation of c-Met. This regulation menchaism promotes glioma pathogenesis and may provide a potential target for the prognosis and treatment of glioma.

  5. activation of HGF/c-MET signaling in an autocrine fashion leads to an aggressive phenotype in SS and targeting of this signaling exerts superior antitumor effects on c-MET-activated SS. HGF/c-MET expression status is a potential biomarker for identification of SS patients with a worse prognosis who can benefit from c-MET inhibitors.

  6. both EGCG and miR-1 mimic inhibited c-MET expression, and combination treatment with EGCG and c-MET inhibitor (crizotinib) had enhanced inhibitory effects on the growth of MG-63 and U-2OS cells. Taken together, these results suggest that EGCG has an anticancer effect on OS cells, at least partially, through regulating miR-1/c-MET interaction.

  7. This study showed that c-Met expression was not associated with survival outcomes in extrahepatic bile duct cancer patients undergoing curative resection followed by adjuvant chemoradiotherapy

  8. Our data indicate that over-expression of MET and KIT in primary adult soft tissue sarcomas samples and its derived cell lines is associated with miR (show MLXIP Antibodies)-152 down-regulation

  9. complete loss of one or both MET and RON (show MST1R Antibodies), as well as their overexpression, is a poor prognostic factor in patients with extrahepatic cholangiocarcinoma, probably due to the high rate of lymph-node metastasis

  10. c-MET-positive advanced gastric cancer patients had a poorer prognosis than c-MET-negative patients.

Cow (Bovine) Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (MET) antibody
  • hepatocyte growth factor (hepapoietin A; scatter factor) (HGF) antibody
  • hepatocyte growth factor (HGF) antibody
  • hepatoCyte growth factor receptor (Tsp_05936) antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • HGFR antibody
  • MET antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , c-Met , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , HGF receptor c-Met , hepatocyte growth factor , hepatoCyte growth factor receptor , met proto-oncogene , Hepatocyte growth factor receptor , hepatocyte growth factor receptor-like , Proto-oncogene c-Met , Scatter factor receptor , Tyrosine-protein kinase Met

GENE ID SPECIES
100126565 Oryctolagus cuniculus
24553 Rattus norvegicus
4233 Homo sapiens
280855 Bos taurus
403438 Canis lupus familiaris
443075 Ovis aries
463671 Pan troglodytes
493669 Felis catus
708316 Macaca mulatta
10911086 Trichinella spiralis
100126669 Papio anubis
100137030 Pongo abelii
100137502 Ornithorhynchus anatinus
100408551 Callithrix jacchus
Did you look for something else?